Peroxiredoxin 6 is one protein with two chemical jobs. It is a peroxidase, and it is a calcium-independent phospholipase A2. This preprint separates those jobs in HepG2 cells, a human liver-cancer cell line.
The authors built a stable line carrying D140A, a mutation they use to turn off only the phospholipase. They compared it with wild-type cells and with cells that lack the protein entirely. D140A cells kept reactive oxygen species low, in line with wild-type cells. The authors read that as evidence that the oxidative stress of the full knockout comes from losing the peroxidase.
Lipid peroxidation did not follow the reactive oxygen species. D140A cells peroxidized more lipid than wild-type cells, and less than the knockout. On ferrous iron, lipid droplets, and glutathione peroxidase 4, the phospholipase mutant looked like the knockout: iron accumulated, lipid-droplet formation fell, and glutathione peroxidase 4 was down. Proteomics, lipidomics, and enzyme assays pointed to a failure to release lipid species the cells use for structure and signaling. Peroxisomes, endoplasmic reticulum, mitochondria, and lipid droplets were all affected.
In mitochondria the abstract is specific. Cristae were reduced. Mitophagy and autophagy were diminished. The cells died more readily when challenged with erastin, an experimental inducer of ferroptosis. The authors also report that the inhibitor MJ33 lowered phospholipase activity to a level comparable to D140A. That is a cell-line observation. It is not a therapy.
Metal and redox
The iron species named here is intracellular ferrous iron. Glutathione peroxidase 4 is named as a ferroptosis regulator that fell. The peroxidase activity of peroxiredoxin 6 is the control that stayed intact in D140A, which is why reactive oxygen species stayed low. No iron-sulfur nuclearity, no heme, and no copper site is reported. Do not add one.
What this does not show
The work is a preprint in one cancer cell line, read here from the abstract. The missing lipids are not named. Ferrous iron is not traced to a particular enzyme. This page is not a treatment plan, and it does not recommend MJ33 or any other inhibitor.
